Aurintricarboxylic acid inhibits influenza virus neuraminidase

被引:93
作者
Hung, Hui-Chen [1 ]
Tseng, Ching-Ping [1 ]
Yang, Jinn-Moon [2 ]
Ju, Yi-Wei [1 ]
Tseng, Sung-Nain [3 ]
Chen, Yen-Fu [2 ]
Chao, Yu-Sheng [4 ]
Hsieh, Hsing-Pang [4 ]
Shih, Shin-Ru [3 ,5 ]
Hsu, John T. -A. [1 ,4 ]
机构
[1] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan
[2] Natl Chiao Tung Univ, Inst Bioinformat, Hsinchu, Taiwan
[3] Chang Gung Univ, Dept Med Biotechnol, Tao Yuan, Taiwan
[4] Natl Hlth Res Inst, Div Biotechnol & Pharmaceut Res, Miaoli, Taiwan
[5] Chang Gung Mem Hosp, Clin Virol Lab, Tao Yuan, Taiwan
关键词
Aurintricarboxylic acid; Influenza; Neuraminidase; Antivirals; ANTI-HIV ACTIVITIES; IN-VITRO; OSELTAMIVIR CARBOXYLATE; PARAINFLUENZA VIRUS; STRUCTURAL-ANALYSIS; POTENT INHIBITOR; RESISTANT; REPLICATION; DESIGN; TARGET;
D O I
10.1016/j.antiviral.2008.10.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There is a continuing threat that the highly pathogenic avian influenza virus will cause future influenza pandemics. In this study, we screened a library of compounds that are biologically active and structurally diverse for inhibitory activity against influenza neuraminidase (NA). We found that aurintricarboxylic acid (ATA) is a potent inhibitor of NA activity of both group-1 and group-2 influenza viruses with IC50S (effective concentration to inhibit NA activity by 50%) values at low micromolar concentrations. ATA was equally potent in inhibiting the NA activity derived from wild-type NA and its H274Y mutant which renders NA resistance to inhibition by oseltamivir. Although ATA is structurally distinct from sialic acid, molecular modeling experiments suggested that ATA binds to NA at the enzyme's substrate binding site. These results indicate that ATA may be a good starting material for the design of a novel class of NA inhibitors for the treatment influenza viruses. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:123 / 131
页数:9
相关论文
共 63 条
[1]  
Abed Y, 2006, ANTIVIR THER, V11, P971
[2]   Aurintricarboxylic acid inhibits apoptosis and supports proliferation in a haemopoietic growth-factor dependent myeloid cell line [J].
Andrew, DJ ;
Hay, AWM ;
Evans, SW .
IMMUNOPHARMACOLOGY, 1999, 41 (01) :1-10
[3]   AURINTRICARBOXYLIC ACID AND EVANS BLUE REPRESENT 2 DIFFERENT CLASSES OF ANIONIC COMPOUNDS WHICH SELECTIVELY INHIBIT THE CYTOPATHOGENICITY OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-III LYMPHADENOPATHY-ASSOCIATED VIRUS [J].
BALZARINI, J ;
MITSUYA, H ;
DECLERCQ, E ;
BRODER, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 136 (01) :64-71
[4]   Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir [J].
Baz, Mariana ;
Abed, Yacine ;
Boivin, Guy .
ANTIVIRAL RESEARCH, 2007, 74 (02) :159-162
[5]   Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and Evans blue [J].
Beery, R ;
Haimsohn, M ;
Wertheim, N ;
Hemi, R ;
Nir, U ;
Karasik, A ;
Kanety, H ;
Geier, A .
ENDOCRINOLOGY, 2001, 142 (07) :3098-3107
[6]   AURINTRICARBOXYLIC ACID, A PUTATIVE INHIBITOR OF APOPTOSIS, IS A POTENT INHIBITOR OF DNA TOPOISOMERASE-II IN-VITRO AND IN CHINESE-HAMSTER FIBROSARCOMA CELLS [J].
BENCHOKROUN, Y ;
COUPRIE, J ;
LARSEN, AK .
BIOCHEMICAL PHARMACOLOGY, 1995, 49 (03) :305-313
[7]   Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo [J].
Carr, J ;
Ives, J ;
Kelly, L ;
Lambkin, R ;
Oxford, J ;
Mendel, D ;
Tai, L ;
Roberts, N .
ANTIVIRAL RESEARCH, 2002, 54 (02) :79-88
[8]  
Chang Shih-Cheng, 2006, Chang Gung Med J, V29, P130
[9]   Inhibition of cytokine-induced JAK-STAT signalling pathways by an endonuclease inhibitor aurintricarboxylic acid [J].
Chen, CW ;
Chao, Y ;
Chang, YH ;
Hsu, MJ ;
Lin, WW .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 137 (07) :1011-1020
[10]   Purification and characterization of human prolyl dipeptidase DPPS in Sf9 insect cells [J].
Chen, YS ;
Chien, CH ;
Goparaju, CM ;
Hsu, JTA ;
Liang, PH ;
Chen, X .
PROTEIN EXPRESSION AND PURIFICATION, 2004, 35 (01) :142-146